Skip to content

A longitudinal study of chronic pain and its associations with suicidality and respective risk factors

A longitudinal study of chronic pain and its associations with suicidality and respective risk factors - ChronAS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00033155
Enrollment
200
Registered
2024-02-29
Start date
2024-03-07
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain (>3 months) and suicidality

Interventions

Group 1: German-speaking persons with chronic pain over the age of 18 are surveyed at baseline (T1) about their demographics, their chronic pain and their pain experience (pain anamnesis, DASS - Depre

Sponsors

Universität Duisburg-Essen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: fluent in German, Chronic pain (i.e., pain lasting > 3 months)

Exclusion criteria

Exclusion criteria: Not meeting the inclusion criteria, non-adults (<18 years old), not suffering from chronic pain, participants giving an incorrect answer on the attention check item

Design outcomes

Primary

MeasureTime frame
1) Assessment of chronic pain and pain experiences (z. B. pain severity, DASS – Depression Anxiety and Stress Scale, CPAQ-D – Chronic Pain Acceptance Questionnaire, PCS – Pain Catastrophizing Scale, IEQ – Injustice Experience Questionnaire) at baseline (T1) and 4-week Follow-up (T2) and its association with suicidal ideation and behavior at T1 and T2 (SSEV-Skala Suizidales Erleben und Verhalten [Scale for Suicidal Experience and Behavior]) 2) Assessment of chronic pain and pain experiences at T1 and T2 and its association with proximal risk factors of suicidality at T1 and T2 (ES – Entrapment Scale, SDES – Short Defeat and Entrapment Scale, INQ – Interpersonal Needs Questionnaire, GCSQ – German Capability of Suicide Questionnaire) 3) Investigation of the motivational phase of the IMV model (O’Connor & Kirtley, 2018); Assessment of the factors Defeat and Entrapment at T1 and T2 (ES – Entrapment Scale, SDES – Short Defeat and Entrapment Scale) and their relation to suicidal ideation and behavior at T1 and T2 (SSEV – Skala Suizidales Erleben und Verhalten [Scale for Suicidal Experience and Behavior])

Secondary

MeasureTime frame
4) Examining the differences between chronic primary pain and chronic secondary pain in terms of subgroup analyses for the primary outcomes (1) and (2) 5) Assessment of ambivalence attitudes towards suicide in chronic pain (SAS – Suizidale Ambivalenz Skala [Suicidal Ambivalence Scale]) and its association with suicidal ideation and behavior (SSEV – Skala Suizidales Erleben und Verhalten [Scale for Suicidal Experience and Behavior]) 6) Assessment of Positive Mental Health (PMH-Scale – Positive Mental Health Scale) and social support (OSSS-3 – Oslo Social Support Scale) and their function as protective factors regarding the association between Entrapment (T1) (ES – Entrapment Scale) and suicidal ideation (T1 and T2) (SSEV – Skala Suizidales Erleben und Verhalten [Scale for Suicidal Experience and Behavior]) in the IMV model (O’Connor & Kirtley, 2018) in persons living with chronic pain 7) Assessment of Pain Catastrophizing (T1; PCS – Pain Catastrophizing Scale) and its association with proximal risk factors (T1 and T2; ES – Entrapment Scale, SDES – Short Defeat and Entrapment Scale) and the development of suicidal ideation and behavior (T1 and T2; SSEV – Skala Suizidales Erleben und Verhalten [Scale for Suicidal Experience and Behavior]) in persons living with chronic pain 8) Assessment of Attitudes towards assisted suicide in persons living with chronic pain (Questionnaire based on a survey of the Berlin Institute of social research; Wassiliwizky et al., 2022)

Countries

Austria, Belgium, Germany, Liechtenstein, Luxembourg, Switzerland

Contacts

Public ContactBeatrice Korwisi

Universität Duisburg-Essen

beatrice.korwisi@uni-due.de+49 201 183 6441

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026